Identification and evaluation of a potent novel ATR inhibitor, NU6027, in breast and ovarian cancer cell linesAmy Peasland, Nicola J. Curtin, William A. Cliby et al.|British Journal of Cancer|2011Cited by 193
The synergistic interaction of MEK and PI3K inhibitors is modulated by mTOR inhibitionEmma J. Haagensen, David R. Newell, Suzanne Kyle et al.|British Journal of Cancer|2012Cited by 83
Abstract 5399: Growth inhibition, cytotoxicity and signaling studies of PI3K & MEK inhibitor combinations in colorectal carcinoma cell linesEmma J. Cox, David R. Newell, Ross J. Maxwell et al.|Cancer Research|2010Cited by 0